Eksigent Licenses Microfluidics Technologies from Sandia Labs | GenomeWeb

NEW YORK, Aug 14 – Eksigent Technologies has announced that it has licensed Sandia National Laboratories’ microfluidics technology.

Eksigent and Sandia, both of Livermore, Calif., did not disclose the terms of the deal or describe the specific technologies involved. Sandia licensed Eksigent the technology through its tech transfer program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.